Home
RSSThe leading Indian drugmaker Ranbaxy Laboratories Ltd. said on Tuesday it has submitted a bid for the generics unit of Germany’s Merck KGaA.
The buy-out of the unit could be worth as much as 5 billion Euros (US $6.58 billion), analysts...
Related Stories
Most Recent
Most Popular
Most Commented
12
Star It 
(4)
Sustainable development has become a buzzword these days. While there is nothing wrong with the concept, can sustainable development really be achieved or is it just an...
made popular Jun 2 2008
Its very sad to see the poor cattle ranchers of the Amazon region, especially of Alta Floresta being sandwiched between the Government’s simultaneous efforts at...
made popular Apr 12 2008
World Wildlife Fund had launched this print advertisement campaign in its fund raising efforts. The campaign is urging people to donate just few coins to support the...
made popular Jul 5 2007
This is an interesting guerilla advertisement campaign at the Spanish coastline launched by Greenpeace Spain to create awareness about dumping of toxic waste and...
made popular May 21 2007
The decision of TXU Corp.’s to whittle down plans to build 11 coal-fired power plants to accomplish acquisition process smoothly has clearly indicated that...
made popular Feb 27 2007
All Stories
Most Recent
Most Popular
Most Commented
The decision of TXU Corp.’s to whittle down plans to build 11 coal-fired power plants to accomplish acquisition process smoothly has clearly indicated that...
made popular Feb 27 2007
Related Tags
Agreement Business Business Deal Environment Conservation Germany Indian business Merck Ranbaxy
